Literature DB >> 26944050

Incidence of post-cataract endophthalmitis with intracameral cefuroxime.

Colin S H Tan1,2, Louis W Lim3, Vernon S Chow3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26944050     DOI： 10.1007/s00417-016-3287-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  7 in total

1.  Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery.

Authors:  Pedro Romero; Isabel Méndez; Merce Salvat; Juan Fernández; Matias Almena
Journal:  J Cataract Refract Surg       Date:  2006-03       Impact factor: 3.351

2.  Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study.

Authors:  Maria Carmen García-Sáenz; Alfonso Arias-Puente; Gil Rodríguez-Caravaca; Josefina B Bañuelos
Journal:  J Cataract Refract Surg       Date:  2010-02       Impact factor: 3.351

3.  Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agents.

Authors:  Colin S H Tan; Hon Kiat Wong; Francine P Yang
Journal:  J Cataract Refract Surg       Date:  2012-01-15       Impact factor: 3.351

4.  Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: an Israeli experience.

Authors:  Gabriel Katz; Sharon Blum; Omer Leeva; Ruth Axer-Siegel; Joseph Moisseiev; Gili Tesler; Rita Ehrlich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-24       Impact factor: 3.117

5.  Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery.

Authors:  Per G Montan; Gisela Wejde; Gabor Koranyi; Margareta Rylander
Journal:  J Cataract Refract Surg       Date:  2002-06       Impact factor: 3.351

6.  Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.

Authors: 
Journal:  J Cataract Refract Surg       Date:  2007-06       Impact factor: 3.351

7.  Prophylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-year study.

Authors:  Magela Garat; Carlos L Moser; Montserrat Martín-Baranera; Carles Alonso-Tarrés; Luis Alvarez-Rubio
Journal:  J Cataract Refract Surg       Date:  2009-04       Impact factor: 3.351
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.